These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28536725)

  • 41. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diseases linked to Helicobacter pylori infection].
    Gisbert JP
    Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():40-52. PubMed ID: 25294265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection.
    Fashner J; Gitu AC
    Am Fam Physician; 2015 Feb; 91(4):236-42. PubMed ID: 25955624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
    Zhou L; Zhang J; Song Z; He L; Li Y; Qian J; Bai P; Xue Y; Wang Y; Lin S
    Helicobacter; 2016 Apr; 21(2):91-9. PubMed ID: 26104022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection].
    Campillo A; Ostiz M; Amorena E; Kutz M; La Iglesia M
    Med Clin (Barc); 2016 Sep; 147(5):199-201. PubMed ID: 27374029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of 13C-urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitratobismuthate in non-ulcer dyspepsia.
    Dill S; Payne-James JJ; Misiewicz JJ; Grimble GK; McSwiggan D; Pathak K; Wood AJ; Scrimgeour CM; Rennie MJ
    Gut; 1990 Nov; 31(11):1237-41. PubMed ID: 2253905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?
    Gisbert JP; Olivares D; Jimenez I; Pajares JM
    Dig Liver Dis; 2006 Apr; 38(4):254-9. PubMed ID: 16309984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second-line bismuth-containing quadruple therapy for
    Kim SE; Park MI; Park SJ; Moon W; Kim JH; Jung K; Kim HK; Lee YD
    World J Gastroenterol; 2017 Feb; 23(6):1059-1066. PubMed ID: 28246480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
    Gisbert JP; Castro-Fernández M; Bermejo F; Pérez-Aisa A; Ducons J; Fernández-Bermejo M; Bory F; Cosme A; Benito LM; López-Rivas L; Lamas E; Pabón M; Olivares D;
    Am J Gastroenterol; 2006 Feb; 101(2):243-7. PubMed ID: 16454825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Helicobacter pylori in functional dyspepsia.
    O'Morain C
    World J Gastroenterol; 2006 May; 12(17):2677-80. PubMed ID: 16718752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Smith S; Boyle B; Brennan D; Buckley M; Crotty P; Doyle M; Farrell R; Hussey M; Kevans D; Malfertheiner P; Megraud F; Nugent S; O'Connor A; O'Morain C; Weston S; McNamara D
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):552-559. PubMed ID: 28350745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic susceptibility of Helicobacter pylori in Iceland.
    Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
    Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
    Onal IK; Gokcan H; Benzer E; Bilir G; Oztas E
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):642-6. PubMed ID: 23796974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ; Vakil N; Ballard ED; Fennerty MB
    N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Malfertheiner P; Megraud F; O'Morain CA; Gisbert JP; Kuipers EJ; Axon AT; Bazzoli F; Gasbarrini A; Atherton J; Graham DY; Hunt R; Moayyedi P; Rokkas T; Rugge M; Selgrad M; Suerbaum S; Sugano K; El-Omar EM;
    Gut; 2017 Jan; 66(1):6-30. PubMed ID: 27707777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.